Speaker(s): 

Ryan Zimmerman, MD, Resident Physician, Geisinger - has nothing to disclose.

Mentor(s):

Varun Pulakanti, MD, Attending Physician, Geisinger - disclosures with Biogen, TG Therapeutics, Novartis, and Alexion

Learning Objectives:

• examine prior ICH trial data for use of minimally invasive surgery in ICH
• interpret the use of adaptive trials and Bayesian probability in clinical research
• analyze the trial data to determine if it supports the claim authors are making

At the conclusion of this session, the participant should be able to answer the following questions:

• what is MIPS surgery?
• how did the ENRICH trial incorporate prior trial data?
• what is the utility weighted MRS and is it a good measure in this patient population?

Disclosure of Relevant Financial Relationships with/without Commercial Interests:

The Planning Committee consisting of Dana Vanino, DO, Cortney Houtz, LPN, Joy Hill, RN, and Sarah Ruhl have no identified disclosures. 

CE Committee Member/Content Reviewers have nothing to disclose. 

Any/All relevant financial relationships have been mitigated. 

Content Disclosure: 

This presentation/content is HIPAA compliant. 

Commercial Support for this Session

None